Global Therapeutic Radioisotopes Sales Market Report 2021

The global Therapeutic Radioisotopes market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Radioisotopes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Radium-223

Lutetium-177

Iodine-131

Other

Thyroid

Bone Metastasis

Lymphoma

Other

The Therapeutic Radioisotopes market is analysed and market size information is provided by regions (countries). Segment by Application, the Therapeutic Radioisotopes market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

Bayer

Novartis

China Isotope & Radiation

Dongcheng

Q BioMed

Curium Pharmaceuticals

Jubilant DraxImage

Lantheus

Spectrum Pharmaceuticals

Progenics Pharmaceuticals

International Isotopes

1.1 Therapeutic Radioisotopes Product Scope

1.2 Therapeutic Radioisotopes Segment by Type

1.2.1 Global Therapeutic Radioisotopes Sales by Type (2016 & 2021 & 2027)

1.2.2 Radium-223

1.2.3 Lutetium-177

1.2.4 Iodine-131

1.2.5 Other

1.3 Therapeutic Radioisotopes Segment by Application

1.3.1 Global Therapeutic Radioisotopes Sales Comparison by Application (2016 & 2021 & 2027)

1.3.2 Thyroid

1.3.3 Bone Metastasis

1.3.4 Lymphoma

1.3.5 Other

1.4 Therapeutic Radioisotopes Market Estimates and Forecasts (2016-2027)

1.4.1 Global Therapeutic Radioisotopes Market Size in Value Growth Rate (2016-2027)

1.4.2 Global Therapeutic Radioisotopes Market Size in Volume Growth Rate (2016-2027)

1.4.3 Global Therapeutic Radioisotopes Price Trends (2016-2027)

2.1 Global Therapeutic Radioisotopes Market Size by Region: 2016 VS 2021 VS 2027

2.2 Global Therapeutic Radioisotopes Retrospective Market Scenario by Region (2016-2021)

2.2.1 Global Therapeutic Radioisotopes Sales Market Share by Region (2016-2021)

2.2.2 Global Therapeutic Radioisotopes Revenue Market Share by Region (2016-2021)

2.3 Global Therapeutic Radioisotopes Market Estimates and Forecasts by Region (2022-2027)

2.3.1 Global Therapeutic Radioisotopes Sales Estimates and Forecasts by Region (2022-2027)

2.3.2 Global Therapeutic Radioisotopes Revenue Forecast by Region (2022-2027)

2.4 Geographic Market Analysis: Market Facts & Figures

2.4.1 North America Therapeutic Radioisotopes Estimates and Projections (2016-2027)

2.4.2 Europe Therapeutic Radioisotopes Estimates and Projections (2016-2027)

2.4.3 China Therapeutic Radioisotopes Estimates and Projections (2016-2027)

2.4.4 Japan Therapeutic Radioisotopes Estimates and Projections (2016-2027)

2.4.5 Southeast Asia Therapeutic Radioisotopes Estimates and Projections (2016-2027)

2.4.6 India Therapeutic Radioisotopes Estimates and Projections (2016-2027)

3.1 Global Top Therapeutic Radioisotopes Players by Sales (2016-2021)

3.2 Global Top Therapeutic Radioisotopes Players by Revenue (2016-2021)

3.3 Global Therapeutic Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Therapeutic Radioisotopes as of 2020)

3.4 Global Therapeutic Radioisotopes Average Price by Company (2016-2021)

3.5 Manufacturers Therapeutic Radioisotopes Manufacturing Sites, Area Served, Product Type

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.1 Global Therapeutic Radioisotopes Historic Market Review by Type (2016-2021)

4.1.1 Global Therapeutic Radioisotopes Sales Market Share by Type (2016-2021)

4.1.2 Global Therapeutic Radioisotopes Revenue Market Share by Type (2016-2021)

4.1.3 Global Therapeutic Radioisotopes Price by Type (2016-2021)

4.2 Global Therapeutic Radioisotopes Market Estimates and Forecasts by Type (2022-2027)

4.2.1 Global Therapeutic Radioisotopes Sales Forecast by Type (2022-2027)

4.2.2 Global Therapeutic Radioisotopes Revenue Forecast by Type (2022-2027)

4.2.3 Global Therapeutic Radioisotopes Price Forecast by Type (2022-2027)

5.1 Global Therapeutic Radioisotopes Historic Market Review by Application (2016-2021)

5.1.1 Global Therapeutic Radioisotopes Sales Market Share by Application (2016-2021)

5.1.2 Global Therapeutic Radioisotopes Revenue Market Share by Application (2016-2021)

5.1.3 Global Therapeutic Radioisotopes Price by Application (2016-2021)

5.2 Global Therapeutic Radioisotopes Market Estimates and Forecasts by Application (2022-2027)

5.2.1 Global Therapeutic Radioisotopes Sales Forecast by Application (2022-2027)

5.2.2 Global Therapeutic Radioisotopes Revenue Forecast by Application (2022-2027)

5.2.3 Global Therapeutic Radioisotopes Price Forecast by Application (2022-2027)

6.1 North America Therapeutic Radioisotopes Sales by Company

6.1.1 North America Therapeutic Radioisotopes Sales by Company (2016-2021)

6.1.2 North America Therapeutic Radioisotopes Revenue by Company (2016-2021)

6.2 North America Therapeutic Radioisotopes Sales Breakdown by Type

6.2.1 North America Therapeutic Radioisotopes Sales Breakdown by Type (2016-2021)

6.2.2 North America Therapeutic Radioisotopes Sales Breakdown by Type (2022-2027)

6.3 North America Therapeutic Radioisotopes Sales Breakdown by Application

6.3.1 North America Therapeutic Radioisotopes Sales Breakdown by Application (2016-2021)

6.3.2 North America Therapeutic Radioisotopes Sales Breakdown by Application (2022-2027)

7.1 Europe Therapeutic Radioisotopes Sales by Company

7.1.1 Europe Therapeutic Radioisotopes Sales by Company (2016-2021)

7.1.2 Europe Therapeutic Radioisotopes Revenue by Company (2016-2021)

7.2 Europe Therapeutic Radioisotopes Sales Breakdown by Type

7.2.1 Europe Therapeutic Radioisotopes Sales Breakdown by Type (2016-2021)

7.2.2 Europe Therapeutic Radioisotopes Sales Breakdown by Type (2022-2027)

7.3 Europe Therapeutic Radioisotopes Sales Breakdown by Application

7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)

7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)

8.1 China Therapeutic Radioisotopes Sales by Company

8.1.1 China Therapeutic Radioisotopes Sales by Company (2016-2021)

8.1.2 China Therapeutic Radioisotopes Revenue by Company (2016-2021)

8.2 China Therapeutic Radioisotopes Sales Breakdown by Type

8.2.1 China Therapeutic Radioisotopes Sales Breakdown by Type (2016-2021)

8.2.2 China Therapeutic Radioisotopes Sales Breakdown by Type (2022-2027)

8.3 China Therapeutic Radioisotopes Sales Breakdown by Application

8.3.1 China 312 Sales Breakdown by Application (2016-2021)

8.3.2 China 312 Sales Breakdown by Application (2022-2027)

9.1 Japan Therapeutic Radioisotopes Sales by Company

9.1.1 Japan Therapeutic Radioisotopes Sales by Company (2016-2021)

9.1.2 Japan Therapeutic Radioisotopes Revenue by Company (2016-2021)

9.2 Japan Therapeutic Radioisotopes Sales Breakdown by Type

9.2.1 Japan Therapeutic Radioisotopes Sales Breakdown by Type (2016-2021)

9.2.2 Japan Therapeutic Radioisotopes Sales Breakdown by Type (2022-2027)

9.3 Japan Therapeutic Radioisotopes Sales Breakdown by Application

9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)

9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10.1 Southeast Asia Therapeutic Radioisotopes Sales by Company

10.1.1 Southeast Asia Therapeutic Radioisotopes Sales by Company (2016-2021)

10.1.2 Southeast Asia Therapeutic Radioisotopes Revenue by Company (2016-2021)

10.2 Southeast Asia Therapeutic Radioisotopes Sales Breakdown by Type

10.2.1 Southeast Asia Therapeutic Radioisotopes Sales Breakdown by Type (2016-2021)

10.2.2 Southeast Asia Therapeutic Radioisotopes Sales Breakdown by Type (2022-2027)

10.3 Southeast Asia Therapeutic Radioisotopes Sales Breakdown by Application

10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)

10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11.1 India Therapeutic Radioisotopes Sales by Company

11.1.1 India Therapeutic Radioisotopes Sales by Company (2016-2021)

11.1.2 India Therapeutic Radioisotopes Revenue by Company (2016-2021)

11.2 India Therapeutic Radioisotopes Sales Breakdown by Type

11.2.1 India Therapeutic Radioisotopes Sales Breakdown by Type (2016-2021)

11.2.2 India Therapeutic Radioisotopes Sales Breakdown by Type (2022-2027)

11.3 India Therapeutic Radioisotopes Sales Breakdown by Application

11.3.1 India Therapeutic Radioisotopes Sales Breakdown by Application (2016-2021)

11.3.2 India Therapeutic Radioisotopes Sales Breakdown by Application (2022-2027)

12.1 Bayer

12.1.1 Bayer Corporation Information

12.1.2 Bayer Business Overview

12.1.3 Bayer Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)

12.1.4 Bayer Therapeutic Radioisotopes Products Offered

12.1.5 Bayer Recent Development

12.2 Novartis

12.2.1 Novartis Corporation Information

12.2.2 Novartis Business Overview

12.2.3 Novartis Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)

12.2.4 Novartis Therapeutic Radioisotopes Products Offered

12.2.5 Novartis Recent Development

12.3 China Isotope & Radiation

12.3.1 China Isotope & Radiation Corporation Information

12.3.2 China Isotope & Radiation Business Overview

12.3.3 China Isotope & Radiation Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)

12.3.4 China Isotope & Radiation Therapeutic Radioisotopes Products Offered

12.3.5 China Isotope & Radiation Recent Development

12.4 Dongcheng

12.4.1 Dongcheng Corporation Information

12.4.2 Dongcheng Business Overview

12.4.3 Dongcheng Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)

12.4.4 Dongcheng Therapeutic Radioisotopes Products Offered

12.4.5 Dongcheng Recent Development

12.5 Q BioMed

12.5.1 Q BioMed Corporation Information

12.5.2 Q BioMed Business Overview

12.5.3 Q BioMed Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)

12.5.4 Q BioMed Therapeutic Radioisotopes Products Offered

12.5.5 Q BioMed Recent Development

12.6 Curium Pharmaceuticals

12.6.1 Curium Pharmaceuticals Corporation Information

12.6.2 Curium Pharmaceuticals Business Overview

12.6.3 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)

12.6.4 Curium Pharmaceuticals Therapeutic Radioisotopes Products Offered

12.6.5 Curium Pharmaceuticals Recent Development

12.7 Jubilant DraxImage

12.7.1 Jubilant DraxImage Corporation Information

12.7.2 Jubilant DraxImage Business Overview

12.7.3 Jubilant DraxImage Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)

12.7.4 Jubilant DraxImage Therapeutic Radioisotopes Products Offered

12.7.5 Jubilant DraxImage Recent Development

12.8 Lantheus

12.8.1 Lantheus Corporation Information

12.8.2 Lantheus Business Overview

12.8.3 Lantheus Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)

12.8.4 Lantheus Therapeutic Radioisotopes Products Offered

12.8.5 Lantheus Recent Development

12.9 Spectrum Pharmaceuticals

12.9.1 Spectrum Pharmaceuticals Corporation Information

12.9.2 Spectrum Pharmaceuticals Business Overview

12.9.3 Spectrum Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)

12.9.4 Spectrum Pharmaceuticals Therapeutic Radioisotopes Products Offered

12.9.5 Spectrum Pharmaceuticals Recent Development

12.10 Progenics Pharmaceuticals

12.10.1 Progenics Pharmaceuticals Corporation Information

12.10.2 Progenics Pharmaceuticals Business Overview

12.10.3 Progenics Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)

12.10.4 Progenics Pharmaceuticals Therapeutic Radioisotopes Products Offered

12.10.5 Progenics Pharmaceuticals Recent Development

12.11 International Isotopes

12.11.1 International Isotopes Corporation Information

12.11.2 International Isotopes Business Overview

12.11.3 International Isotopes Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)

12.11.4 International Isotopes Therapeutic Radioisotopes Products Offered

12.11.5 International Isotopes Recent Development

13.1 Therapeutic Radioisotopes Key Raw Materials Analysis

13.1.1 Key Raw Materials

13.1.2 Key Raw Materials Price Trend

13.1.3 Key Suppliers of Raw Materials

13.2 Proportion of Manufacturing Cost Structure

13.3 Manufacturing Process Analysis of Therapeutic Radioisotopes

13.4 Therapeutic Radioisotopes Industrial Chain Analysis

14.1 Marketing Channel

14.2 Therapeutic Radioisotopes Distributors List

14.3 Therapeutic Radioisotopes Customers

15.1 Therapeutic Radioisotopes Market Trends

15.2 Therapeutic Radioisotopes Drivers

15.3 Therapeutic Radioisotopes Market Challenges

15.4 Therapeutic Radioisotopes Market Restraints

17.1 Research Methodology

17.1.1 Methodology/Research Approach

17.1.2 Data Source

17.2 Author List

17.3 Disclaimer

List of Tables

    Table 1. Global Therapeutic Radioisotopes Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)

    Table 2. Global Therapeutic Radioisotopes Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)

    Table 3. Global Therapeutic Radioisotopes Market Size (US$ Million) by Region: 2016 VS 2021 &2027

    Table 4. Global Therapeutic Radioisotopes Sales (K Units) by Region (2016-2021)

    Table 5. Global Therapeutic Radioisotopes Sales Market Share by Region (2016-2021)

    Table 6. Global Therapeutic Radioisotopes Revenue (US$ Million) Market Share by Region (2016-2021))

    Table 7. Global Therapeutic Radioisotopes Revenue Share by Region (2016-2021)

    Table 8. Global Therapeutic Radioisotopes Sales (K Units) Forecast by Region (2022-2027)

    Table 9. Global Therapeutic Radioisotopes Sales Market Share Forecast by Region (2022-2027)

    Table 10. Global Therapeutic Radioisotopes Revenue (US$ Million) Forecast by Region (2022-2027)

    Table 11. Global Therapeutic Radioisotopes Revenue Share Forecast by Region (2022-2027)

    Table 12. Global Therapeutic Radioisotopes Sales (K Units) of Key Companies (2016-2021)

    Table 13. Global Therapeutic Radioisotopes Sales Share by Company (2016-2021)

    Table 14. Global Therapeutic Radioisotopes Revenue (US$ Million) by Company (2016-2021)

    Table 15. Global Therapeutic Radioisotopes Revenue Share by Company (2016-2021)

    Table 16. Global Therapeutic Radioisotopes by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Radioisotopes as of 2020)

    Table 17. Global Therapeutic Radioisotopes Average Price (USD/Unit) of Key Company (2016-2021)

    Table 18. Manufacturers Therapeutic Radioisotopes Manufacturing Sites and Area Served

    Table 19. Manufacturers Therapeutic Radioisotopes Product Type

    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 21. Global Therapeutic Radioisotopes Sales (K Units) by Type (2016-2021)

    Table 22. Global Therapeutic Radioisotopes Sales Share by Type (2016-2021)

    Table 23. Global Therapeutic Radioisotopes Revenue (US$ Million) Market Share by Type (2016-2021)

    Table 24. Global Therapeutic Radioisotopes Price (USD/Unit) by Type (2016-2021)

    Table 25. Global Therapeutic Radioisotopes Sales Share by Type (2022-2027)

    Table 26. Global Therapeutic Radioisotopes Revenue (US$ Million) Market Share by Type (2022-2027)

    Table 27. Global Therapeutic Radioisotopes Revenue Share by Type (2022-2027)

    Table 28. Global Therapeutic Radioisotopes Price (USD/Unit) by Type (2022-2027)

    Table 29. Global Therapeutic Radioisotopes Sales (K Units) by Application (2016-2021)

    Table 30. Global Therapeutic Radioisotopes Sales Share by Application (2016-2021)

    Table 31. Global Therapeutic Radioisotopes Revenue (US$ Million) Market Share by Application (2016-2021)

    Table 32. Global Therapeutic Radioisotopes Price (USD/Unit) by Application (2016-2021)

    Table 33. Global Therapeutic Radioisotopes Sales (K Units) by Application (2022-2027)

    Table 34. Global Therapeutic Radioisotopes Sales Share by Application (2022-2027)

    Table 35. Global Therapeutic Radioisotopes Revenue (US$ Million) Market Share by Application (2022-2027)

    Table 36. Global Therapeutic Radioisotopes Revenue Share by Application (2022-2027)

    Table 37. Global Therapeutic Radioisotopes Price (USD/Unit) by Application (2022-2027)

    Table 38. North America Therapeutic Radioisotopes Sales (K Units) by Company (2016-2021)

    Table 39. North America Therapeutic Radioisotopes Sales Market Share by Company (2016-2021)

    Table 40. North America Therapeutic Radioisotopes Revenue by Company (2016-2021) & (US$ Million)

    Table 41. North America Therapeutic Radioisotopes Revenue Market Share by Company (2016-2021)

    Table 42. North America Therapeutic Radioisotopes Sales by Type (2016-2021) & (K Units)

    Table 43. North America Therapeutic Radioisotopes Sales Market Share by Type (2016-2021)

    Table 44. North America Therapeutic Radioisotopes Sales by Type (2022-2027) & (K Units)

    Table 45. North America Therapeutic Radioisotopes Sales Market Share by Type (2022-2027)

    Table 46. North America Therapeutic Radioisotopes Sales by Application (2016-2021) & (K Units)

    Table 47. North America Therapeutic Radioisotopes Sales Market Share by Application (2016-2021)

    Table 48. North America Therapeutic Radioisotopes Sales by Application (2022-2027) & (K Units)

    Table 49. North America Therapeutic Radioisotopes Sales Market Share by Application (2022-2027)

    Table 50. Europe Therapeutic Radioisotopes Sales (K Units) by Company (2016-2021)

    Table 51. Europe Therapeutic Radioisotopes Sales Market Share by Company (2016-2021)

    Table 52. Europe Therapeutic Radioisotopes Revenue by Company (2016-2021) & (US$ Million)

    Table 53. Europe Therapeutic Radioisotopes Revenue Market Share by Company (2016-2021)

    Table 54. Europe Therapeutic Radioisotopes Sales by Type (2016-2021) & (K Units)

    Table 55. Europe Therapeutic Radioisotopes Sales Market Share by Type (2016-2021)

    Table 56. Europe Therapeutic Radioisotopes Sales by Type (2022-2027) & (K Units)

    Table 57. Europe Therapeutic Radioisotopes Sales Market Share by Type (2022-2027)

    Table 58. Europe Therapeutic Radioisotopes Sales by Application (2016-2021) & (K Units)

    Table 59. Europe Therapeutic Radioisotopes Sales Market Share by Application (2016-2021)

    Table 60. Europe Therapeutic Radioisotopes Sales by Application (2022-2027) & (K Units)

    Table 61. Europe Therapeutic Radioisotopes Sales Market Share by Application (2022-2027)

    Table 62. China Therapeutic Radioisotopes Sales (K Units) by Company (2016-2021)

    Table 63. China Therapeutic Radioisotopes Sales Market Share by Company (2016-2021)

    Table 64. China Therapeutic Radioisotopes Revenue by Company (2016-2021) & (US$ Million)

    Table 65. China Therapeutic Radioisotopes Revenue Market Share by Company (2016-2021)

    Table 66. China Therapeutic Radioisotopes Sales by Type (2016-2021) & (K Units)

    Table 67. China Therapeutic Radioisotopes Sales Market Share by Type (2016-2021)

    Table 68. China Therapeutic Radioisotopes Sales by Type (2022-2027) & (K Units)

    Table 69. China Therapeutic Radioisotopes Sales Market Share by Type (2022-2027)

    Table 70. China Therapeutic Radioisotopes Sales by Application (2016-2021) & (K Units)

    Table 71. China Therapeutic Radioisotopes Sales Market Share by Application (2016-2021)

    Table 72. China Therapeutic Radioisotopes Sales by Application (2022-2027) & (K Units)

    Table 73. China Therapeutic Radioisotopes Sales Market Share by Application (2022-2027)

    Table 74. Japan Therapeutic Radioisotopes Sales (K Units) by Company (2016-2021)

    Table 75. Japan Therapeutic Radioisotopes Sales Market Share by Company (2016-2021)

    Table 76. Japan Therapeutic Radioisotopes Revenue by Company (2016-2021) & (US$ Million)

    Table 77. Japan Therapeutic Radioisotopes Revenue Market Share by Company (2016-2021)

    Table 78. Japan Therapeutic Radioisotopes Sales by Type (2016-2021) & (K Units)

    Table 79. Japan Therapeutic Radioisotopes Sales Market Share by Type (2016-2021)

    Table 80. Japan Therapeutic Radioisotopes Sales by Type (2022-2027) & (K Units)

    Table 81. Japan Therapeutic Radioisotopes Sales Market Share by Type (2022-2027)

    Table 82. Japan Therapeutic Radioisotopes Sales by Application (2016-2021) & (K Units)

    Table 83. Japan Therapeutic Radioisotopes Sales Market Share by Application (2016-2021)

    Table 84. Japan Therapeutic Radioisotopes Sales by Application (2022-2027) & (K Units)

    Table 85. Japan Therapeutic Radioisotopes Sales Market Share by Application (2022-2027)

    Table 86. Southeast Asia Therapeutic Radioisotopes Sales (K Units) by Company (2016-2021)

    Table 87. Southeast Asia Therapeutic Radioisotopes Sales Market Share by Company (2016-2021)

    Table 88. Southeast Asia Therapeutic Radioisotopes Revenue by Company (2016-2021) & (US$ Million)

    Table 89. Southeast Asia Therapeutic Radioisotopes Revenue Market Share by Company (2016-2021)

    Table 90. Southeast Asia Therapeutic Radioisotopes Sales by Type (2016-2021) & (K Units)

    Table 91. Southeast Asia Therapeutic Radioisotopes Sales Market Share by Type (2016-2021)

    Table 92. Southeast Asia Therapeutic Radioisotopes Sales by Type (2022-2027) & (K Units)

    Table 93. Southeast Asia Therapeutic Radioisotopes Sales Market Share by Type (2022-2027)

    Table 94. Southeast Asia Therapeutic Radioisotopes Sales by Application (2016-2021) & (K Units)

    Table 95. Southeast Asia Therapeutic Radioisotopes Sales Market Share by Application (2016-2021)

    Table 96. Southeast Asia Therapeutic Radioisotopes Sales by Application (2022-2027) & (K Units)

    Table 97. Southeast Asia Therapeutic Radioisotopes Sales Market Share by Application (2022-2027)

    Table 98. India Therapeutic Radioisotopes Sales (K Units) by Company (2016-2021)

    Table 99. India Therapeutic Radioisotopes Sales Market Share by Company (2016-2021)

    Table 100. India Therapeutic Radioisotopes Revenue by Company (2016-2021) & (US$ Million)

    Table 101. India Therapeutic Radioisotopes Revenue Market Share by Company (2016-2021)

    Table 102. India Therapeutic Radioisotopes Sales by Type (2016-2021) & (K Units)

    Table 103. India Therapeutic Radioisotopes Sales Market Share by Type (2016-2021)

    Table 104. India Therapeutic Radioisotopes Sales by Type (2022-2027) & (K Units)

    Table 105. India Therapeutic Radioisotopes Sales Market Share by Type (2022-2027)

    Table 106. India Therapeutic Radioisotopes Sales by Application (2016-2021) & (K Units)

    Table 107. India Therapeutic Radioisotopes Sales Market Share by Application (2016-2021)

    Table 108. India Therapeutic Radioisotopes Sales by Application (2022-2027) & (K Units)

    Table 109. India Therapeutic Radioisotopes Sales Market Share by Application (2022-2027)

    Table 110. Bayer Corporation Information

    Table 111. Bayer Description and Business Overview

    Table 112. Bayer Therapeutic Radioisotopes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 113. Bayer Therapeutic Radioisotopes Product

    Table 114. Bayer Recent Development

    Table 115. Novartis Corporation Information

    Table 116. Novartis Description and Business Overview

    Table 117. Novartis Therapeutic Radioisotopes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 118. Novartis Therapeutic Radioisotopes Product

    Table 119. Novartis Recent Development

    Table 120. China Isotope & Radiation Corporation Information

    Table 121. China Isotope & Radiation Description and Business Overview

    Table 122. China Isotope & Radiation Therapeutic Radioisotopes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 123. China Isotope & Radiation Therapeutic Radioisotopes Product

    Table 124. China Isotope & Radiation Recent Development

    Table 125. Dongcheng Corporation Information

    Table 126. Dongcheng Description and Business Overview

    Table 127. Dongcheng Therapeutic Radioisotopes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 128. Dongcheng Therapeutic Radioisotopes Product

    Table 129. Dongcheng Recent Development

    Table 130. Q BioMed Corporation Information

    Table 131. Q BioMed Description and Business Overview

    Table 132. Q BioMed Therapeutic Radioisotopes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 133. Q BioMed Therapeutic Radioisotopes Product

    Table 134. Q BioMed Recent Development

    Table 135. Curium Pharmaceuticals Corporation Information

    Table 136. Curium Pharmaceuticals Description and Business Overview

    Table 137. Curium Pharmaceuticals Therapeutic Radioisotopes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 138. Curium Pharmaceuticals Therapeutic Radioisotopes Product

    Table 139. Curium Pharmaceuticals Recent Development

    Table 140. Jubilant DraxImage Corporation Information

    Table 141. Jubilant DraxImage Description and Business Overview

    Table 142. Jubilant DraxImage Therapeutic Radioisotopes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 143. Jubilant DraxImage Therapeutic Radioisotopes Product

    Table 144. Jubilant DraxImage Recent Development

    Table 145. Lantheus Corporation Information

    Table 146. Lantheus Therapeutic Radioisotopes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 147. Lantheus Description and Business Overview

    Table 148. Lantheus Therapeutic Radioisotopes Product

    Table 149. Lantheus Recent Development

    Table 150. Spectrum Pharmaceuticals Corporation Information

    Table 151. Spectrum Pharmaceuticals Therapeutic Radioisotopes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 152. Spectrum Pharmaceuticals Description and Business Overview

    Table 153. Spectrum Pharmaceuticals Therapeutic Radioisotopes Product

    Table 154. Spectrum Pharmaceuticals Recent Development

    Table 155. Progenics Pharmaceuticals Corporation Information

    Table 156. Progenics Pharmaceuticals Description and Business Overview

    Table 157. Progenics Pharmaceuticals Therapeutic Radioisotopes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 158. Progenics Pharmaceuticals Therapeutic Radioisotopes Product

    Table 159. Progenics Pharmaceuticals Recent Development

    Table 160. International Isotopes Corporation Information

    Table 161. International Isotopes Description and Business Overview

    Table 162. International Isotopes Therapeutic Radioisotopes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 163. International Isotopes Therapeutic Radioisotopes Product

    Table 164. International Isotopes Recent Development

    Table 165. Production Base and Market Concentration Rate of Raw Material

    Table 166. Key Suppliers of Raw Materials

    Table 167. Therapeutic Radioisotopes Distributors List

    Table 168. Therapeutic Radioisotopes Customers List

    Table 169. Therapeutic Radioisotopes Market Trends

    Table 170. Therapeutic Radioisotopes Market Drivers

    Table 171. Therapeutic Radioisotopes Market Challenges

    Table 172. Therapeutic Radioisotopes Market Restraints

    Table 173. Research Programs/Design for This Report

    Table 174. Key Data Information from Secondary Sources

    Table 175. Key Data Information from Primary Sources

List of Figures

    Figure 1. Therapeutic Radioisotopes Product Picture

    Figure 2. Global Therapeutic Radioisotopes Sales Market Share by Type in 2021 & 2027

    Figure 3. Type I Product Picture

    Figure 4. Type II Product Picture

    Figure 5. Global Therapeutic Radioisotopes Sales Market Share by Application in 2021 & 2027

    Figure 6. Thyroid Examples

    Figure 7. Bone Metastasis Examples

    Figure 8. Lymphoma Examples

    Figure 9. Other Examples

    Figure 10. Global Therapeutic Radioisotopes Sales, (US$ Million), 2016 VS 2021 VS 2027

    Figure 11. Global Therapeutic Radioisotopes Sales Growth Rate (2016-2027) & (US$ Million)

    Figure 12. Global Therapeutic Radioisotopes Sales (K Units) Growth Rate (2016-2027)

    Figure 13. Global Therapeutic Radioisotopes Price Trends Growth Rate (2016-2027) (USD/Unit)

    Figure 14. Global Therapeutic Radioisotopes Revenue Market Share by Region: 2016 VS 2021

    Figure 15. Global Therapeutic Radioisotopes Revenue Market Share by Region: 2021 VS 2027

    Figure 16. North America Therapeutic Radioisotopes Revenue (Million USD) Growth Rate (2016-2027)

    Figure 17. North America Therapeutic Radioisotopes Sales (K Units) Growth Rate (2016-2027)

    Figure 18. Europe Therapeutic Radioisotopes Revenue (Million USD) Growth Rate (2016-2027)

    Figure 19. Europe Therapeutic Radioisotopes Sales (Million USD) Growth Rate (2016-2027)

    Figure 20. China Therapeutic Radioisotopes Revenue (Million USD) Growth Rate (2016-2027)

    Figure 21. China Therapeutic Radioisotopes Sales (Million USD) and Growth Rate (2016-2027)

    Figure 22. Japan Therapeutic Radioisotopes Revenue (Million USD) Growth Rate (2016-2027)

    Figure 23. Japan Therapeutic Radioisotopes Sales (Million USD) Growth Rate (2016-2027)

    Figure 24. Southeast Asia Therapeutic Radioisotopes Revenue (Million USD) Growth Rate (2016-2027)

    Figure 25. Southeast Asia Therapeutic Radioisotopes Sales (Million USD) Growth Rate (2016-2027)

    Figure 26. India Therapeutic Radioisotopes Revenue (Million USD) Growth Rate (2016-2027)

    Figure 27. India Therapeutic Radioisotopes Sales (Million USD) Growth Rate (2016-2027)

    Figure 28. Global 5 Largest Therapeutic Radioisotopes Players Market Share by Revenue in Therapeutic Radioisotopes: 2016 & 2020

    Figure 29. Therapeutic Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020

    Figure 30. Global Therapeutic Radioisotopes Revenue Share by Type (2016-2021)

    Figure 31. Global Therapeutic Radioisotopes Revenue Growth Rate by Type in 2016 & 2020

    Figure 32. Global Therapeutic Radioisotopes Revenue Share by Application (2016-2021)

    Figure 33. Global Therapeutic Radioisotopes Revenue Growth Rate by Application in 2016 & 2020

    Figure 34. North America Therapeutic Radioisotopes Sales Market Share by Type in 2020

    Figure 35. North America Therapeutic Radioisotopes Sales Market Share by Application in 2020

    Figure 36. Europe Therapeutic Radioisotopes Sales Market Share by Type in 2020

    Figure 37. Europe Therapeutic Radioisotopes Sales Market Share by Application in 2020

    Figure 38. China Therapeutic Radioisotopes Sales Market Share by Type in 2020

    Figure 39. China Therapeutic Radioisotopes Sales Market Share by Application in 2020

    Figure 40. Japan Therapeutic Radioisotopes Sales Market Share by Type in 2020

    Figure 41. Japan Therapeutic Radioisotopes Sales Market Share by Application in 2020

    Figure 42. Southeast Asia Therapeutic Radioisotopes Sales Market Share by Type in 2020

    Figure 43. Southeast Asia Therapeutic Radioisotopes Sales Market Share by Application in 2020

    Figure 44. India Therapeutic Radioisotopes Sales Market Share by Type in 2020

    Figure 45. India Therapeutic Radioisotopes Sales Market Share by Application in 2020

    Figure 46. Key Raw Materials Price Trend

    Figure 47. Manufacturing Cost Structure of Therapeutic Radioisotopes

    Figure 48. Manufacturing Process Analysis of Therapeutic Radioisotopes

    Figure 49. Therapeutic Radioisotopes Industrial Chain Analysis

    Figure 50. Channels of Distribution

    Figure 51. Distributors Profiles

    Figure 52. Bottom-up and Top-down Approaches for This Report

    Figure 53. Data Triangulation

    Figure 54. Key Executives Interviewed